01:52 PM EDT, 07/11/2025 (MT Newswires) -- Health care stocks declined Friday afternoon, with the NYSE Health Care Index down 1.2% and the Health Care Select Sector SPDR Fund (XLV) falling 1.1%.

The iShares Biotechnology ETF (IBB) shed 1.3%.

In sector news, the US Food and Drug Administration may fast-track new drugs from pharmaceutical companies that "equalize" the prices of their medicines between the US and other countries, Commissioner Marty Makary said in an interview on Bloomberg Television.

In corporate news, Walgreens Boots Alliance ( WBA ) said its shareholders approved the acquisition of the company by entities affiliated with Sycamore Partners Management. Walgreens shares were shedding 0.3%.

Capricor Therapeutics ( CAPR ) shares tumbled 32% after it said the US Food and Drug Administration has required additional clinical data on deramiocel, a cell therapy candidate for cardiomyopathy in Duchenne muscular dystrophy patients.

GSK (GSK), Pfizer ( PFE ) , and Boehringer Ingelheim prevailed as the Delaware Supreme Court reversed a lower court's decision to admit expert testimony in nearly 75,000 Zantac-related cancer lawsuits, the court said. GSK shares were falling 2.8%, and Pfizer ( PFE ) shed 0.5%.

MiNK Therapeutics ( INKT ) shares rallied 700% after a report said a patient with metastatic, treatment-resistant testicular cancer achieved "complete and durable remission" following treatment with its investigational allogeneic iNKT cell therapy.